<?xml version="1.0" encoding="UTF-8"?>
<ref id="B36">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Chen</surname>
    <given-names>L.-R.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Y.-C.</given-names>
   </name>
   <name>
    <surname>Lin</surname>
    <given-names>Y. W.</given-names>
   </name>
   <name>
    <surname>Chou</surname>
    <given-names>S.-Y.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>S.-F.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>L. T.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2005</year>). 
  <article-title>Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors.</article-title>
  <source>
   <italic>Bioorg. Med. Chem. Lett.</italic>
  </source>
  <volume>15</volume>
  <fpage>3058</fpage>â€“
  <lpage>3062</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.bmcl.2005.04.027</pub-id>
  <?supplied-pmid 15896959?>
  <pub-id pub-id-type="pmid">15896959</pub-id>
 </mixed-citation>
</ref>
